News & Events
Filter by Company or Category or search below
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
New technology offered in three unique shapes expands the company’s comprehensive stroke system, allowing physicians to achieve fast and consistent intracranial access July 17, 2024 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc.,
Axtria Announces its First Ignite Leadership Award Honorees
Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry Axtria, a global leader in cloud software and data analytics for the life sciences industry, has announced the recipients of its first-ever
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
151 subjects enrolled in various stages of loading and randomization in SOL-1 pivotal study of AXPAXLI in wet AMD as of June 7, 2024 Announces plans for SOL-R study to evaluate repeat doses of AXPAXLI
Axtria Ignite 2024: A Celebration of Innovation and Leadership in Life Sciences
Join us on June 12-13 in Princeton, New Jersey, for an inspiring event featuring life sciences experts, thought leaders, and award winners. Axtria, Inc., a global leader in cloud software and data analytics for the
Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study
Clinical investigators achieve significant milestone by enrolling 150 patients with hypervascular tumors in pivotal randomized study. BEDFORD, Mass., – May 14, 2024 – Instylla, Inc., a privately held clinical-stage company focused on developing liquid embolics for